GCM
SSRI

Graham Capital Management’s Silver Standard Resources SSRI Stock Holding History

Graham Capital Management’s Portfolio SSRI Stock Details SSRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200,000
Closed -$1.39M – 165
2013
Q4 		$1.39M Sell
200,000
-481,800
-71% -$2.91M 0.08% 89
2013
Q3 		$4.19M Buy
681,800
+286,800
+73% +$2.15M 0.26% 63
2013
Q2 		$2.5M Buy
+395,000
New +$2.91M 0.17% 51

Other funds holding SSRI

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
GXMC
Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
NCM
Newgate Capital Management Greenwich, Connecticut $121M AUM 3.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return